New strategy of α-and γ-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures

Nephrology Dialysis Transplantation

Volumn 28, Issue 2, 2013, Pages 337-344

  Tasanarong, Adis ^a   Vohakiat, Anchalee ^a   Hutayanon, Pisit ^a   Piyayotai, Dilok ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

Author keywords

tocopherol; tocopherol; contrast induced acute kidney injury (CI AKI); coronary procedures; vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CREATININE; GAMMA TOCOPHEROL; IOPROMIDE; PLACEBO;

ABDOMINAL DISCOMFORT; ACUTE KIDNEY FAILURE; AGED; ANEMIA; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR PROCEDURE; CHRONIC KIDNEY DISEASE; CONTRAST INDUCED ACUTE KIDNEY INJURY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; ELECTIVE CORONARY PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ACUTE KIDNEY INJURY; ADMINISTRATION, ORAL; AGED; ALPHA-TOCOPHEROL; ANTIOXIDANTS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; DOUBLE-BLIND METHOD; FEMALE; GAMMA-TOCOPHEROL; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84874538130     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs525     Document Type: Article

References (45)

1. Berns AS. Nephrotoxicity of contrast media. Kidney Int 1989; 36: 730-740 (Pubitemid 19239569)
2. Gurm HS, Smith DE, Berwanger O et al. Contemporary use and effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention. JACC Cardiovasc Interv 2012; 5: 98-104
3. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation 2011; 124: 1250-1259
4. Rudnick MR, Goldfarb S, Tumlin J. Contrast-induced nephropathy: is the picture any clearer? Clin J Am Soc Nephrol 2008; 3: 261-262
5. Thomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 2003; 76: 513-518 (Pubitemid 37028403)
6. Gami AS, Garovic VD. Contrast nephropathy after coronary angiography. Mayo Clin Proc 2004; 79: 211-219 (Pubitemid 38140805)
7. Freeman RV, O'Donnell M, Share D et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002; 90: 1068-1073 (Pubitemid 35335595)
8. Nikolsky E, Mehran R, Turcot D et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 2004; 94: 300-305 (Pubitemid 38962693)
9. Gruberg L, Mintz GS, Mehran R et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000; 36: 1542-1548
10. Brezis M, Rosen S. Hypoxia of the renal medulla-its implications for disease. N Engl J Med 1995; 332: 647-655
11. Tumlin J, Stacul F, Adam A et al. Pathophysiology of contrastinduced nephropathy. Am J Cardiol 2006; 98: 14K-20K
12. Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 2005; 172: 1461-1471 (Pubitemid 40803495)
13. Mueller C, Buerkle G, Buettner HJ et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329-336 (Pubitemid 34127411)
14. Aspelin P, Aubry P, Fransson SG et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491-499 (Pubitemid 36159884)
15. Stacul F, Adam A, Becker CR et al. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 2006; 98: 59K-77K
16. Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrastinduced nephropathy. JAMA 2006; 295: 2765-2779
17. Fishbane S, Durham JH, Marzo K et al. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 2004; 15: 251-260 (Pubitemid 38140765)
18. Spargias K, Alexopoulos E, Kyrzopoulos S et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004; 110: 2837-2842 (Pubitemid 39473606)
19. Boscheri A, Weinbrenner C, Botzek B et al. Failure of ascorbic acid to prevent contrast-media induced nephropathy in patients with renal dysfunction. Clin Nephrol 2007; 68: 279-286 (Pubitemid 350047760)
20. Kamal-Eldin A, Appelqvist LA. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 1996; 31: 671-701 (Pubitemid 26240763)
21. Reiter E, Jiang Q, Christen S. Anti-inflammatory properties of alpha-and gamma-tocopherol. Mol Aspects Med 2007; 28: 668-691
22. Dillioglugil MO, Maral Kir H, Gulkac MD et al. Protective effects of increasing vitamin E and a doses on cisplatin-induced oxidative damage to kidney tissue in rats. Urol Int 2005; 75: 340-344 (Pubitemid 41752584)
23. Shimizu MH, Araujo M, Borges SM et al. Influence of age and vitamin E on post-ischemic acute renal failure. Exp Gerontol 2004; 39: 825-830 (Pubitemid 38586823)
24. Tucker JM, Townsend DM. Alpha-tocopherol: roles in prevention and therapy of human disease. Biomed Pharmacother 2005; 59: 380-387 (Pubitemid 41219652)
25. Ohrvall M, Sundlof G, Vessby B. Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. J Intern Med 1996; 239: 111-117 (Pubitemid 26043146)
26. Singh U, Devaraj S, Jialal I. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr 2005; 25: 151-174
27. Traber MG, Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic Biol Med 2007; 43: 4-15
28. Wang X, Quinn PJ. Vitamin E and its function in membranes. Prog Lipid Res 1999; 38: 309-336 (Pubitemid 29408248)
29. Mehran R, Aymong ED, Nikolsky E et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393-1399 (Pubitemid 39303939)
30. Tepel M. Preventing nephropathy induced by contrast medium. N Engl J Med 2006; 354: 1853-1855. author reply 1855
31. Briguori C, Colombo A, Violante A et al. Standard versus double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 2004; 25: 206-211 (Pubitemid 38235156)
32. Persson PB, Hansell P, Liss P. Pathophysiology of contrast mediuminduced nephropathy. Kidney Int 2005; 68: 14-22
33. Sendeski MM. Pathophysiology of renal tissue damage by iodinated contrast media. Clin Exp Pharmacol Physiol 2011; 38: 292-299
34. Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2004; 24: 469-473 (Pubitemid 39361056)
35. Vaziri ND, Dicus M, Ho ND et al. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int 2003; 63: 179-185 (Pubitemid 35463919)
36. Terawaki H, Yoshimura K, Hasegawa T et al. Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int 2004; 66: 1988-1993
37. Pannu N, Manns B, Lee H et al. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 2004; 65: 1366-1374 (Pubitemid 38406975)
38. Jo SH, Koo BK, Park JS et al. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial. Am Heart J 2009; 157: 576-583
39. Azzi A, Stocker A. Vitamin E: non-antioxidant roles. Prog Lipid Res 2000; 39: 231-255
40. Tasanarong A, Piyayotai D, Thitiarchakul S. Protection of radiocontrast induced nephropathy by vitamin E (alpha tocopherol): a randomized controlled pilot study. J Med Assoc Thai 2009; 92: 1273-1281
41. Evans HM, Bishop KS. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 1922; 56: 650-651
42. Burton GW, Joyce A, Ingold KU. First proof that vitamin E is major lipid-soluble, chain-breaking antioxidant in human blood plasma. Lancet 1982; 2: 327 (Pubitemid 12089629)
43. Burton GW, Cheeseman KH, Doba T et al. Vitamin E as an antioxidant in vitro and in vivo. Ciba Found Symp 1983; 101: 4-18
44. Sies H, Stahl W, Sundquist AR. Antioxidant functions of vitamins. Vitamins E and C, beta-carotene, and other carotenoids. Ann N Y Acad Sci 1992; 669: 7-20 (Pubitemid 23009923)
45. Urbschat A, Obermuller N, Haferkamp A. Biomarkers of kidney injury. Biomarkers 2011; 16 (Suppl 1): S22-S30